[
  {
    "ts": null,
    "headline": "Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp",
    "summary": "Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapiesPITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models exclusively for Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services. As part of an ongoing agreement, Predictive Onco",
    "url": "https://finnhub.io/api/news?id=db2329b8547e01ed057c4f0193c441e6ff9122af5e51ca5f9dd98d7ac99bce27",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749731400,
      "headline": "Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp",
      "id": 135220987,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapiesPITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models exclusively for Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services. As part of an ongoing agreement, Predictive Onco",
      "url": "https://finnhub.io/api/news?id=db2329b8547e01ed057c4f0193c441e6ff9122af5e51ca5f9dd98d7ac99bce27"
    }
  }
]